Correlation Between Dynavax Technologies and Pacira BioSciences,
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and Pacira BioSciences,, you can compare the effects of market volatilities on Dynavax Technologies and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Pacira BioSciences,.
Diversification Opportunities for Dynavax Technologies and Pacira BioSciences,
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Dynavax and Pacira is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Pacira BioSciences, go up and down completely randomly.
Pair Corralation between Dynavax Technologies and Pacira BioSciences,
Given the investment horizon of 90 days Dynavax Technologies is expected to generate 1.78 times more return on investment than Pacira BioSciences,. However, Dynavax Technologies is 1.78 times more volatile than Pacira BioSciences,. It trades about 0.18 of its potential returns per unit of risk. Pacira BioSciences, is currently generating about 0.01 per unit of risk. If you would invest 1,087 in Dynavax Technologies on August 24, 2024 and sell it today you would earn a total of 149.00 from holding Dynavax Technologies or generate 13.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dynavax Technologies vs. Pacira BioSciences,
Performance |
| Timeline |
| Dynavax Technologies |
| Pacira BioSciences, |
Dynavax Technologies and Pacira BioSciences, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dynavax Technologies and Pacira BioSciences,
The main advantage of trading using opposite Dynavax Technologies and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.| Dynavax Technologies vs. Alkermes Plc | Dynavax Technologies vs. Neurocrine Biosciences | Dynavax Technologies vs. Intracellular Th | Dynavax Technologies vs. Aquestive Therapeutics |
| Pacira BioSciences, vs. Phibro Animal Health | Pacira BioSciences, vs. Dr Reddys Laboratories | Pacira BioSciences, vs. Collegium Pharmaceutical | Pacira BioSciences, vs. Prestige Brand Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |